Skip to main content

A Phase I Dose-Escalation Study of Carfilzomib in Patients with Previously-Treated Systemic Light-Chain (AL) Amyloidosis

Publication ,  Conference
Cohen, AD; Scott, EC; Liedtke, M; Kaufman, JL; Landau, H; Vesole, DH; Gomes, CL; Gasparetto, C; Lentzsch, S; Rosenzweig, M; Sanchorawala, V ...
Published in: BLOOD
December 6, 2014

Duke Scholars

Published In

BLOOD

EISSN

1528-0020

ISSN

0006-4971

Publication Date

December 6, 2014

Volume

124

Issue

21

Location

San Francisco, CA

Publisher

AMER SOC HEMATOLOGY

Conference Name

56th Annual Meeting of the American-Society-of-Hematology

Related Subject Headings

  • Immunology
  • 3213 Paediatrics
  • 3201 Cardiovascular medicine and haematology
  • 3101 Biochemistry and cell biology
  • 1114 Paediatrics and Reproductive Medicine
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Cohen, A. D., Scott, E. C., Liedtke, M., Kaufman, J. L., Landau, H., Vesole, D. H., … Durie, B. G. M. (2014). A Phase I Dose-Escalation Study of Carfilzomib in Patients with Previously-Treated Systemic Light-Chain (AL) Amyloidosis. In BLOOD (Vol. 124). San Francisco, CA: AMER SOC HEMATOLOGY.
Cohen, Adam D., Emma C. Scott, Michaela Liedtke, Jonathan L. Kaufman, Heather Landau, David H. Vesole, Christina L. Gomes, et al. “A Phase I Dose-Escalation Study of Carfilzomib in Patients with Previously-Treated Systemic Light-Chain (AL) Amyloidosis.” In BLOOD, Vol. 124. AMER SOC HEMATOLOGY, 2014.
Cohen AD, Scott EC, Liedtke M, Kaufman JL, Landau H, Vesole DH, et al. A Phase I Dose-Escalation Study of Carfilzomib in Patients with Previously-Treated Systemic Light-Chain (AL) Amyloidosis. In: BLOOD. AMER SOC HEMATOLOGY; 2014.
Cohen, Adam D., et al. “A Phase I Dose-Escalation Study of Carfilzomib in Patients with Previously-Treated Systemic Light-Chain (AL) Amyloidosis.” BLOOD, vol. 124, no. 21, AMER SOC HEMATOLOGY, 2014.
Cohen AD, Scott EC, Liedtke M, Kaufman JL, Landau H, Vesole DH, Gomes CL, Gasparetto C, Lentzsch S, Rosenzweig M, Sanchorawala V, Smith DD, Comenzo RL, Durie BGM. A Phase I Dose-Escalation Study of Carfilzomib in Patients with Previously-Treated Systemic Light-Chain (AL) Amyloidosis. BLOOD. AMER SOC HEMATOLOGY; 2014.

Published In

BLOOD

EISSN

1528-0020

ISSN

0006-4971

Publication Date

December 6, 2014

Volume

124

Issue

21

Location

San Francisco, CA

Publisher

AMER SOC HEMATOLOGY

Conference Name

56th Annual Meeting of the American-Society-of-Hematology

Related Subject Headings

  • Immunology
  • 3213 Paediatrics
  • 3201 Cardiovascular medicine and haematology
  • 3101 Biochemistry and cell biology
  • 1114 Paediatrics and Reproductive Medicine
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology